Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-09-22

AUTHORS

François Lauzier, Bruno Lévy, Patrice Lamarre, Olivier Lesur

ABSTRACT

ObjectiveTo compare the effects of arginine-vasopressin (AVP) and norepinephrine (NE) on hemodynamic variables, organ dysfunction, and adverse events in early hyperdynamic septic shock.Design and settingRandomized, controlled, open-label trial.Patients and participantsTwenty-three patients with early (12 h) hyperdynamic septic shock in two teaching hospitals.InterventionsAVP (0.04–0.20 U min–1, n = 13) as a single agent or NE (0.1–2.8 μg kg–1 min–1, n = 10) infusion for 48 h to achieve mean arterial pressure at or above 70 mmHg.Measurements and resultsHemodynamic parameters and Sequential Organ Failure Assessment (SOFA) score were measured. AVP and NE equally increased mean arterial pressure over 48 h, but NE was required in 36% of AVP patients at 48 h. Compared to baseline, AVP increased systemic vascular resistance, decreased exposure to NE, decreased cardiac output by decreasing heart rate, increased creatinine clearance, and improved SOFA score. The PrCO2 – PaCO2 difference remained stable throughout the study. One AVP patient developed acute coronary syndrome with dose-dependent ECG changes. Three patients in both groups died during their ICU stay.ConclusionIn early hyperdynamic septic shock, the administration of high-dose AVP as a single agent fails to increase mean arterial pressure in the first hour but maintains it above 70 mmHg in two-thirds of patients at 48 h. AVP decreases NE exposure, has no effect on the PrCO2 – PaCO2 difference, and improves renal function and SOFA score. More... »

PAGES

1782-1789

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00134-006-0378-0

DOI

http://dx.doi.org/10.1007/s00134-006-0378-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026854140

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17019548


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arginine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Combinations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Organ Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norepinephrine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Shock, Septic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vasoconstrictor Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vasopressins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Soins Intensifs M\u00e9dicaux et Chirurgicaux, Centre de Recherche Clinique, Centre Hospitalier Universitaire de Sherbrooke, 12\u00e8me Avenue Nord, 3001, J1H\u202f5N4, Sherbrooke, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.411172.0", 
          "name": [
            "Soins Intensifs M\u00e9dicaux et Chirurgicaux, Centre de Recherche Clinique, Centre Hospitalier Universitaire de Sherbrooke, 12\u00e8me Avenue Nord, 3001, J1H\u202f5N4, Sherbrooke, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lauzier", 
        "givenName": "Fran\u00e7ois", 
        "id": "sg:person.01066142337.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066142337.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de R\u00e9animation M\u00e9dicale, H\u00f4pital Central, Centre Hospitalier Universitaire de Nancy, Nancy, France", 
          "id": "http://www.grid.ac/institutes/grid.410527.5", 
          "name": [
            "Service de R\u00e9animation M\u00e9dicale, H\u00f4pital Central, Centre Hospitalier Universitaire de Nancy, Nancy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00e9vy", 
        "givenName": "Bruno", 
        "id": "sg:person.01013070630.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013070630.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "D\u00e9partement de Pharmacie, Centre Hospitalier Universitaire de Sherbrooke, 12\u00e8me Avenue Nord, 3001, J1H\u202f5N4, Sherbrooke, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.411172.0", 
          "name": [
            "D\u00e9partement de Pharmacie, Centre Hospitalier Universitaire de Sherbrooke, 12\u00e8me Avenue Nord, 3001, J1H\u202f5N4, Sherbrooke, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lamarre", 
        "givenName": "Patrice", 
        "id": "sg:person.01240770655.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240770655.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Soins Intensifs M\u00e9dicaux et Chirurgicaux, Centre de Recherche Clinique, Centre Hospitalier Universitaire de Sherbrooke, 12\u00e8me Avenue Nord, 3001, J1H\u202f5N4, Sherbrooke, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.411172.0", 
          "name": [
            "Soins Intensifs M\u00e9dicaux et Chirurgicaux, Centre de Recherche Clinique, Centre Hospitalier Universitaire de Sherbrooke, 12\u00e8me Avenue Nord, 3001, J1H\u202f5N4, Sherbrooke, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lesur", 
        "givenName": "Olivier", 
        "id": "sg:person.01200400064.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200400064.05"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s001340101014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044320120", 
          "https://doi.org/10.1007/s001340101014"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001340050931", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007286393", 
          "https://doi.org/10.1007/s001340050931"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-09-22", 
    "datePublishedReg": "2006-09-22", 
    "description": "ObjectiveTo compare the effects of arginine-vasopressin (AVP) and norepinephrine (NE) on hemodynamic variables, organ dysfunction, and adverse events in early hyperdynamic septic shock.Design and settingRandomized, controlled, open-label trial.Patients and participantsTwenty-three patients with early (12\u202fh) hyperdynamic septic shock in two teaching hospitals.InterventionsAVP (0.04\u20130.20 U\u202fmin\u20131, n\u202f=\u202f13) as a\u00a0single agent or NE (0.1\u20132.8\u202f\u03bcg\u202fkg\u20131\u202fmin\u20131, n\u202f=\u202f10) infusion for 48\u202fh to achieve mean arterial pressure at or above 70\u202fmmHg.Measurements and resultsHemodynamic parameters and Sequential Organ Failure Assessment (SOFA) score were measured. AVP and NE equally increased mean arterial pressure over 48\u202fh, but NE was required in 36% of AVP patients at 48\u202fh. Compared to baseline, AVP increased systemic vascular resistance, decreased exposure to NE, decreased cardiac output by decreasing heart rate, increased creatinine clearance, and improved SOFA score. The PrCO2 \u2013 PaCO2 difference remained stable throughout the study. One AVP patient developed acute coronary syndrome with dose-dependent ECG changes. Three patients in both groups died during their ICU stay.ConclusionIn early hyperdynamic septic shock, the administration of high-dose AVP as a\u00a0single agent fails to increase mean arterial pressure in the first hour but maintains it above 70\u202fmmHg in two-thirds of patients at 48\u202fh. AVP decreases NE exposure, has no effect on the PrCO2 \u2013 PaCO2 difference, and improves renal function and SOFA score.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00134-006-0378-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313639", 
        "issn": [
          "0342-4642", 
          "1432-1238"
        ], 
        "name": "Intensive Care Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "keywords": [
      "early hyperdynamic septic shock", 
      "hyperdynamic septic shock", 
      "mean arterial pressure", 
      "arginine-vasopressin", 
      "septic shock", 
      "arterial pressure", 
      "AVP patients", 
      "SOFA score", 
      "single agent", 
      "Sequential Organ Failure Assessment score", 
      "Organ Failure Assessment score", 
      "open-label trial", 
      "systemic vascular resistance", 
      "acute coronary syndrome", 
      "ICU stay", 
      "vascular resistance", 
      "creatinine clearance", 
      "coronary syndrome", 
      "renal function", 
      "organ dysfunction", 
      "adverse events", 
      "NE infusion", 
      "ECG changes", 
      "hemodynamic variables", 
      "cardiac output", 
      "clinical trials", 
      "teaching hospital", 
      "heart rate", 
      "NE exposure", 
      "patients", 
      "norepinephrine", 
      "assessment scores", 
      "two-thirds", 
      "first hour", 
      "mmHg", 
      "scores", 
      "trials", 
      "exposure", 
      "stay", 
      "dysfunction", 
      "infusion", 
      "syndrome", 
      "hospital", 
      "agents", 
      "shock", 
      "vasopressin", 
      "ObjectiveTo", 
      "administration", 
      "baseline", 
      "clearance", 
      "differences", 
      "pressure", 
      "hours", 
      "effect", 
      "group", 
      "study", 
      "rate", 
      "events", 
      "resistance", 
      "changes", 
      "function", 
      "variables", 
      "measurements", 
      "output", 
      "parameters", 
      "design", 
      "InterventionsAVP", 
      "resultsHemodynamic parameters", 
      "Failure Assessment (SOFA) score", 
      "PrCO2 \u2013 PaCO2 difference", 
      "dose-dependent ECG changes", 
      "ConclusionIn early hyperdynamic septic shock", 
      "high-dose AVP"
    ], 
    "name": "Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial", 
    "pagination": "1782-1789", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026854140"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00134-006-0378-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17019548"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00134-006-0378-0", 
      "https://app.dimensions.ai/details/publication/pub.1026854140"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_429.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00134-006-0378-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00134-006-0378-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00134-006-0378-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00134-006-0378-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00134-006-0378-0'


 

This table displays all metadata directly associated to this object as RDF triples.

225 TRIPLES      22 PREDICATES      115 URIs      105 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00134-006-0378-0 schema:about N41093f2e19d24b74a7cf3d3407e7d6d0
2 N589d35c103914230b30a47482582eeb1
3 N82f7f815889e4a03a4d2ad49bd7b0468
4 N94bde4705ae74694a16fcc50ea80133d
5 N974e90d7c919489e9d6e4e9ee3a705cd
6 N9b442a8c4fb843f9a0ce7a8b1358acad
7 Nb454f7cb15d64403a137c46f26cc548a
8 Nbf288c0eed684c1a9ba835c9a78c1784
9 Nc9779bb242784c44a7b1777ea2778fe2
10 Nd4944a25c60341b59c33bc04e6c10a3f
11 Ne74cff8340dd4b1ab57055dc72d7ebed
12 Ned40f3522b274a0983fbd4f65b7f0426
13 Nef01aefa6c6a42879e0dd0762766320e
14 Nf2e880392138420b9e762532f3d69586
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N2992c1319d18441fafa6ea51ba89786e
18 schema:citation sg:pub.10.1007/s001340050931
19 sg:pub.10.1007/s001340101014
20 schema:datePublished 2006-09-22
21 schema:datePublishedReg 2006-09-22
22 schema:description ObjectiveTo compare the effects of arginine-vasopressin (AVP) and norepinephrine (NE) on hemodynamic variables, organ dysfunction, and adverse events in early hyperdynamic septic shock.Design and settingRandomized, controlled, open-label trial.Patients and participantsTwenty-three patients with early (12 h) hyperdynamic septic shock in two teaching hospitals.InterventionsAVP (0.04–0.20 U min–1, n = 13) as a single agent or NE (0.1–2.8 μg kg–1 min–1, n = 10) infusion for 48 h to achieve mean arterial pressure at or above 70 mmHg.Measurements and resultsHemodynamic parameters and Sequential Organ Failure Assessment (SOFA) score were measured. AVP and NE equally increased mean arterial pressure over 48 h, but NE was required in 36% of AVP patients at 48 h. Compared to baseline, AVP increased systemic vascular resistance, decreased exposure to NE, decreased cardiac output by decreasing heart rate, increased creatinine clearance, and improved SOFA score. The PrCO2 – PaCO2 difference remained stable throughout the study. One AVP patient developed acute coronary syndrome with dose-dependent ECG changes. Three patients in both groups died during their ICU stay.ConclusionIn early hyperdynamic septic shock, the administration of high-dose AVP as a single agent fails to increase mean arterial pressure in the first hour but maintains it above 70 mmHg in two-thirds of patients at 48 h. AVP decreases NE exposure, has no effect on the PrCO2 – PaCO2 difference, and improves renal function and SOFA score.
23 schema:genre article
24 schema:inLanguage en
25 schema:isAccessibleForFree false
26 schema:isPartOf N110af92be007467e942bed871c730569
27 Nf5dddd22eea24b3d9b41800c51c8c4f5
28 sg:journal.1313639
29 schema:keywords AVP patients
30 ConclusionIn early hyperdynamic septic shock
31 ECG changes
32 Failure Assessment (SOFA) score
33 ICU stay
34 InterventionsAVP
35 NE exposure
36 NE infusion
37 ObjectiveTo
38 Organ Failure Assessment score
39 PrCO2 – PaCO2 difference
40 SOFA score
41 Sequential Organ Failure Assessment score
42 acute coronary syndrome
43 administration
44 adverse events
45 agents
46 arginine-vasopressin
47 arterial pressure
48 assessment scores
49 baseline
50 cardiac output
51 changes
52 clearance
53 clinical trials
54 coronary syndrome
55 creatinine clearance
56 design
57 differences
58 dose-dependent ECG changes
59 dysfunction
60 early hyperdynamic septic shock
61 effect
62 events
63 exposure
64 first hour
65 function
66 group
67 heart rate
68 hemodynamic variables
69 high-dose AVP
70 hospital
71 hours
72 hyperdynamic septic shock
73 infusion
74 mean arterial pressure
75 measurements
76 mmHg
77 norepinephrine
78 open-label trial
79 organ dysfunction
80 output
81 parameters
82 patients
83 pressure
84 rate
85 renal function
86 resistance
87 resultsHemodynamic parameters
88 scores
89 septic shock
90 shock
91 single agent
92 stay
93 study
94 syndrome
95 systemic vascular resistance
96 teaching hospital
97 trials
98 two-thirds
99 variables
100 vascular resistance
101 vasopressin
102 schema:name Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial
103 schema:pagination 1782-1789
104 schema:productId Na9ecf7ab101c42e9a8e5403f0fd1d7c7
105 Ne5ea93cf1d0541e389b88c59944ce3b7
106 Nf3ede0bcf74849e7b32a3fdae5fa6b0a
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026854140
108 https://doi.org/10.1007/s00134-006-0378-0
109 schema:sdDatePublished 2021-12-01T19:18
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher N4e9c789af5ab420fa8ef170bf1c21076
112 schema:url https://doi.org/10.1007/s00134-006-0378-0
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N110af92be007467e942bed871c730569 schema:issueNumber 11
117 rdf:type schema:PublicationIssue
118 N2992c1319d18441fafa6ea51ba89786e rdf:first sg:person.01066142337.60
119 rdf:rest N69465e7ca9a64d47996f96d5d09d7e5e
120 N41093f2e19d24b74a7cf3d3407e7d6d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Infusions, Intravenous
122 rdf:type schema:DefinedTerm
123 N4e9c789af5ab420fa8ef170bf1c21076 schema:name Springer Nature - SN SciGraph project
124 rdf:type schema:Organization
125 N52e6bc81a1ca4d368b07aaba95e4afe1 rdf:first sg:person.01200400064.05
126 rdf:rest rdf:nil
127 N589d35c103914230b30a47482582eeb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Vasoconstrictor Agents
129 rdf:type schema:DefinedTerm
130 N69465e7ca9a64d47996f96d5d09d7e5e rdf:first sg:person.01013070630.53
131 rdf:rest Nb85ef1496ee84da3bd182e3de855c7c9
132 N82f7f815889e4a03a4d2ad49bd7b0468 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Male
134 rdf:type schema:DefinedTerm
135 N94bde4705ae74694a16fcc50ea80133d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Middle Aged
137 rdf:type schema:DefinedTerm
138 N974e90d7c919489e9d6e4e9ee3a705cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Arginine
140 rdf:type schema:DefinedTerm
141 N9b442a8c4fb843f9a0ce7a8b1358acad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Shock, Septic
143 rdf:type schema:DefinedTerm
144 Na9ecf7ab101c42e9a8e5403f0fd1d7c7 schema:name dimensions_id
145 schema:value pub.1026854140
146 rdf:type schema:PropertyValue
147 Nb454f7cb15d64403a137c46f26cc548a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Norepinephrine
149 rdf:type schema:DefinedTerm
150 Nb85ef1496ee84da3bd182e3de855c7c9 rdf:first sg:person.01240770655.74
151 rdf:rest N52e6bc81a1ca4d368b07aaba95e4afe1
152 Nbf288c0eed684c1a9ba835c9a78c1784 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Survival Analysis
154 rdf:type schema:DefinedTerm
155 Nc9779bb242784c44a7b1777ea2778fe2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Drug Combinations
157 rdf:type schema:DefinedTerm
158 Nd4944a25c60341b59c33bc04e6c10a3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Prospective Studies
160 rdf:type schema:DefinedTerm
161 Ne5ea93cf1d0541e389b88c59944ce3b7 schema:name pubmed_id
162 schema:value 17019548
163 rdf:type schema:PropertyValue
164 Ne74cff8340dd4b1ab57055dc72d7ebed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Vasopressins
166 rdf:type schema:DefinedTerm
167 Ned40f3522b274a0983fbd4f65b7f0426 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Humans
169 rdf:type schema:DefinedTerm
170 Nef01aefa6c6a42879e0dd0762766320e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Multiple Organ Failure
172 rdf:type schema:DefinedTerm
173 Nf2e880392138420b9e762532f3d69586 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Female
175 rdf:type schema:DefinedTerm
176 Nf3ede0bcf74849e7b32a3fdae5fa6b0a schema:name doi
177 schema:value 10.1007/s00134-006-0378-0
178 rdf:type schema:PropertyValue
179 Nf5dddd22eea24b3d9b41800c51c8c4f5 schema:volumeNumber 32
180 rdf:type schema:PublicationVolume
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
185 schema:name Clinical Sciences
186 rdf:type schema:DefinedTerm
187 sg:journal.1313639 schema:issn 0342-4642
188 1432-1238
189 schema:name Intensive Care Medicine
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.01013070630.53 schema:affiliation grid-institutes:grid.410527.5
193 schema:familyName Lévy
194 schema:givenName Bruno
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013070630.53
196 rdf:type schema:Person
197 sg:person.01066142337.60 schema:affiliation grid-institutes:grid.411172.0
198 schema:familyName Lauzier
199 schema:givenName François
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066142337.60
201 rdf:type schema:Person
202 sg:person.01200400064.05 schema:affiliation grid-institutes:grid.411172.0
203 schema:familyName Lesur
204 schema:givenName Olivier
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200400064.05
206 rdf:type schema:Person
207 sg:person.01240770655.74 schema:affiliation grid-institutes:grid.411172.0
208 schema:familyName Lamarre
209 schema:givenName Patrice
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240770655.74
211 rdf:type schema:Person
212 sg:pub.10.1007/s001340050931 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007286393
213 https://doi.org/10.1007/s001340050931
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s001340101014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044320120
216 https://doi.org/10.1007/s001340101014
217 rdf:type schema:CreativeWork
218 grid-institutes:grid.410527.5 schema:alternateName Service de Réanimation Médicale, Hôpital Central, Centre Hospitalier Universitaire de Nancy, Nancy, France
219 schema:name Service de Réanimation Médicale, Hôpital Central, Centre Hospitalier Universitaire de Nancy, Nancy, France
220 rdf:type schema:Organization
221 grid-institutes:grid.411172.0 schema:alternateName Département de Pharmacie, Centre Hospitalier Universitaire de Sherbrooke, 12ème Avenue Nord, 3001, J1H 5N4, Sherbrooke, QC, Canada
222 Soins Intensifs Médicaux et Chirurgicaux, Centre de Recherche Clinique, Centre Hospitalier Universitaire de Sherbrooke, 12ème Avenue Nord, 3001, J1H 5N4, Sherbrooke, QC, Canada
223 schema:name Département de Pharmacie, Centre Hospitalier Universitaire de Sherbrooke, 12ème Avenue Nord, 3001, J1H 5N4, Sherbrooke, QC, Canada
224 Soins Intensifs Médicaux et Chirurgicaux, Centre de Recherche Clinique, Centre Hospitalier Universitaire de Sherbrooke, 12ème Avenue Nord, 3001, J1H 5N4, Sherbrooke, QC, Canada
225 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...